Drug intelligence / Profile preview

adipose-derived mesenchymal stem cell supernatant + Pluronic F-127 + hyaluronic acid

Development stage
Preclinical
Modality
Hydrogel Systems → Drug Delivery Systems
Administration
Intraarticular
01

Overview

This is a research-stage injectable thermosensitive composite hydrogel designed for the treatment of knee osteoarthritis. It consists of adipose-derived mesenchymal stem cell (AD-MSC) supernatant, which contains a variety of paracrine factors and bioactive molecules, encapsulated within a matrix of Pluronic F-127 (PF-127) and hyaluronic acid (HA). The formulation acts as a cell-free therapeutic, leveraging the regenerative and anti-inflammatory properties of MSC secretions without the complexities of live cell transplantation. The hydrogel remains in a liquid state at low temperatures (4°C), allowing for easy intra-articular injection, and rapidly transitions into a stable gel at physiological temperature (37°C). This transition provides localized retention and sustained release of the bioactive factors, which have been shown in preclinical models to reduce proinflammatory cytokines (such as IL-1β and TNF-α), decrease cartilage degradation markers (like CTX-II), and preserve joint architecture.

Other names
AD-MSC supernatant-loaded thermosensitive hydrogelAD-MSC conditioned medium + PF-127 + HA hydrogelAD-MSC supernatant + PF-127 + sodium hyaluronate
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on adipose-derived mesenchymal stem cell supernatant + Pluronic F-127 + hyaluronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adipose-derived mesenchymal stem cell supernatant + Pluronic F-127 + hyaluronic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call